Skye Bioscience, Inc Common Stock
Price & Volume
Stats
See more52W Range | $0.56-$5.75 |
Market Cap | $24M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.41 |
News
See moreYahoo Finance • last month
Skye Bioscience outlines 2026 milestones as nimacimab advances toward Phase IIb with new dosing strategy
Yahoo Finance • last month
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Yahoo Finance • 2 months ago
HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE
About
CEO | Mr. Punit S. Dhillon B.A. |
CFO | Mr. John P. Sharp CPA |
Address | 11250 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
